Search

Author/Creator Adachi, Kumiko

3. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. Issue 10333 (9th April 2022)

Authors:
Piccini, Jonathan P; Caso, Valeria; Connolly, Stuart J; Fox, Keith A A; Oldgren, Jonas; Jones, W Schuyler; Gorog, Diana A; Durdil, Václav; Viethen, Thomas; Neumann, Christoph; Mundl, Hardi; Patel, Manesh R; Auer, Johann; Hubauer, Martin; Pandzic, Sead; Preishuber, Eva; Primus-Grabscheit, Carina; ...
Journal:
Lancet
Issue:
Volume 399:Issue 10333(2022)
Page Start:
1383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗